BIOTECH ACQUISITION COMPANY Additional Collateral, Aggregate Fair Value
BIOTECH ACQUISITION COMPANY had Additional Collateral, Aggregate Fair Value of $280.00 million as of 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Notes
us-gaap:AdditionalCollateralAggregateFairValue · last filed 2022-05-16
- 2022-03-31: Additional Collateral, Aggregate Fair Value $280.00M.
- 2021-12-31: Additional Collateral, Aggregate Fair Value $280.00M.
| Period end | Additional Collateral, Aggregate Fair Value |
|---|---|
| 2022-03-31 | $280.00M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $280.00M 10-K · filed 2022-03-08 |